Validity of the Patient-Reported Clinical Global Impression of Change as a Measure of Treatment Response in Men with Premature Ejaculation

被引:28
作者
Althof, Stanley E. [1 ]
Brock, Gerald B. [2 ]
Rosen, Raymond C. [3 ]
Rowland, David L. [4 ]
Aquilina, Joseph W. [5 ]
Rothman, Margaret [6 ]
Tesfaye, Fisseha [5 ]
Bull, Scott [5 ]
机构
[1] Case Western Reserve Univ, Sch Med, Ctr Marital & Sexual Hlth S Florida, W Palm Beach, FL 33401 USA
[2] St Josephs Hlth Ctr, Dept Surg, Div Urol, London, ON, Canada
[3] New England Res Inst, Watertown, MA 02172 USA
[4] Valparaiso Univ, Valparaiso, IN 46383 USA
[5] Johnson & Johnson Pharmaceut Res & Dev LLC, Raritan, NJ USA
[6] Johnson & Johnson Pharmaceut Serv LLC, Raritan, NJ USA
基金
美国国家卫生研究院;
关键词
Premature Ejaculation; Sexual Dysfunction; Clinical Global Impression of Change; Treatment; Dapoxetine; OUTCOME MEASURES; BEHAVIOR CHANGES; VALIDATION; QUESTIONNAIRE; SATISFACTION; DEFINITION; DEMENTIA; TRIALS; WOMEN; SCALE;
D O I
10.1111/j.1743-6109.2010.01793.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction. The Clinical Global Impression of Change (CGIC) measures have high utility in clinical practice. However, it is unknown whether the CGIC is valued for assessing premature ejaculation (PE) symptoms and/or the relationship between CGIC and other validated PE patient-reported measures. Aim. The study aims to assess the validity of the patient-reported CGIC measure in men with PE and to examine the relationship between CGIC ratings and assessments of control, satisfaction, personal distress, and interpersonal difficulty. Methods. Data from a randomized, double-blind, 24-week phase 3 trial in 1,162 men with PE who received dapoxetine (30 mg or 60 mg) or placebo on demand provided the basis for the analysis. Patients were >= 18 years, in a stable monogamous relationship for >= 6 months, met the Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition-Text Revision criteria for PE for >= 6 months, and had an intravaginal ejaculatory latency time (IELT) < 2 minutes in >= 75% of intercourse episodes. Main Outcome Measures. The CGIC asked patients to rate improvement or worsening of their PE compared with the start of the study using a 7-point response scale; other patient-reported measures were control over ejaculation, satisfaction with sexual intercourse, interpersonal difficulty, and personal distress related to ejaculation. Stopwatch-measured IELT was recorded. Associations between CGIC and change in other measures at study end point were assessed. Results. The magnitude of IELT increased for each category of improvement on the CGIC: 1.63, 4.03, and 7.15 minutes for slightly better, better, and much better, respectively. Higher CGIC ratings were correlated with greater improvement in control (r = 0.73), satisfaction (r = 0.62), greater reduction in distress (r = -0.52), and interpersonal difficulty (r = -0.39). Total variance accounted for was 57.4%: control (48.7%), satisfaction (4.5%), IELT (2.8%), and distress (1.15%). Conclusions. The analyses support the validity of the CGIC measure in men with PE. The CGIC can provide clinicians in practice with a valid and brief outcome assessment of their patient's condition. Althof SE, Brock GB, Rosen RC, Rowland DL, Aquilina JW, Rothman M, Tesfaye F, and Bull S. Validity of the patient-reported clinical global impression of change as a measure of treatment response in men with premature ejaculation. J Sex Med 2010;7:2243-2252.
引用
收藏
页码:2243 / 2252
页数:10
相关论文
共 39 条
[21]   Interrelationships among measures of premature ejaculation: The central role of perceived control [J].
Patrick, Donald L. ;
Rowland, David ;
Rothman, Margaret .
JOURNAL OF SEXUAL MEDICINE, 2007, 4 (03) :780-788
[22]   The Premature Ejaculation Profile: validation of self-reported outcome measures for research and practice [J].
Patrick, Donald L. ;
Giuliano, Francois ;
Ho, Kai Fai ;
Gagnon, Dennis D. ;
McNulty, Pauline ;
Rothman, Margaret .
BJU INTERNATIONAL, 2009, 103 (03) :358-364
[23]   Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials [J].
Pryor, Jon L. ;
Althof, Stanley E. ;
Steidle, Christopher ;
Rosen, Raymond C. ;
Hellstrom, Wayne J. G. ;
Shabsigh, Ridwan ;
Miloslavsky, Maja ;
Kell, Sherron .
LANCET, 2006, 368 (9539) :929-937
[24]   Sexual well-being, happiness, and satisfaction, in women: The case for a new conceptual paradigm [J].
Rosen, Raymond C. ;
Bachmann, Gloria A. .
JOURNAL OF SEX & MARITAL THERAPY, 2008, 34 (04) :291-297
[25]   Development and validation of four-item version of male sexual health questionnaire to assess ejaculatory dysfunction [J].
Rosen, Raymond C. ;
Catania, Joseph A. ;
Althof, Stanley E. ;
Pollack, Lance M. ;
O'Leary, Michael ;
Seftel, Allen D. ;
Coon, David W. .
UROLOGY, 2007, 69 (05) :805-809
[26]   The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction [J].
Rosen, RC ;
Riley, A ;
Wagner, G ;
Osterloh, IH ;
Kirkpatrick, J ;
Mishra, A .
UROLOGY, 1997, 49 (06) :822-830
[27]   Self-reported premature ejaculation and aspects of sexual functioning and satisfaction [J].
Rowland, David ;
Perelman, Michael ;
Althof, Stanley ;
Barada, James ;
McCullough, Andrew ;
Bull, Scott ;
Jamieson, Carol ;
Ho, Kai-Fai .
JOURNAL OF SEXUAL MEDICINE, 2004, 1 (02) :225-232
[28]   The psychological burden of premature ejaculation [J].
Rowland, David L. ;
Patrick, Donald L. ;
Rothman, Margaret ;
Gagnon, Dennis D. .
JOURNAL OF UROLOGY, 2007, 177 (03) :1065-1070
[29]  
ROWLAND DL, 2003, B INT SOC SEX IMPOT, V32, P261
[30]   Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetine [J].
Shabsigh, Ridwan ;
Patrick, Donald L. ;
Rowland, David L. ;
Bull, Scott A. ;
Tesfaye, Fisseha ;
Rothman, Margaret .
BJU INTERNATIONAL, 2008, 102 (07) :824-828